Literature DB >> 12184520

Evidence for autonomic dysregulation in the irritable bowel syndrome.

Vishal Gupta1, David Sheffield, G Nicholas Verne.   

Abstract

Irritable bowel syndrome (IBS) is a common gastrointestinal disorder characterized by chronic abdominal pain and visceral hypersensitivity. In this study, resting blood pressure and heart rate were recorded in 20 IBS patients and 23 controls. We assessed pain intensity and unpleasantness to visceral and cutaneous stimuli using rectal distension and immersion of the foot in hot water. Mean resting heart rate was higher in IBS patients compared to controls. IBS patients rated pain intensity and unpleasantness to visceral and cutaneous stimuli significantly higher than controls. In IBS patients, blood pressure was significantly inversely associated with visceral pain and only weakly and positively associated with cutaneous pain; there were no relationships in controls. Sex and anxiety did not explain these relationships. In conclusion, we found evidence suggestive of central autonomic dysregulation in IBS patients.

Entities:  

Mesh:

Year:  2002        PMID: 12184520     DOI: 10.1023/a:1016424007454

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome.

Authors:  R Staud; C J Vierck; R L Cannon; A P Mauderli; D D Price
Journal:  Pain       Date:  2001-03       Impact factor: 6.961

2.  Relationship between pain sensitivity and resting arterial blood pressure in patients with painful temporomandibular disorders.

Authors:  W Maixner; R Fillingim; S Kincaid; A Sigurdsson; M B Harris
Journal:  Psychosom Med       Date:  1997 Sep-Oct       Impact factor: 4.312

3.  Altered cardiovascular/pain regulatory relationships in chronic pain.

Authors:  S Bruehl; J W Burns; J A McCubbin
Journal:  Int J Behav Med       Date:  1998

4.  The cutaneous pricking pain threshold in old age.

Authors:  P Procacci; G Bozza; G Buzzelli; M Della Corte
Journal:  Gerontol Clin (Basel)       Date:  1970

Review 5.  The autonomic nervous system in functional bowel disorders.

Authors:  G Tougas
Journal:  Can J Gastroenterol       Date:  1999-03       Impact factor: 3.522

6.  The relationship between resting systolic blood pressure and cutaneous pain perception in cardiac patients with angina pectoris and controls.

Authors:  D Sheffield; R Krittayaphong; B M Go; C G Christy; P L Biles; D S Sheps
Journal:  Pain       Date:  1997-07       Impact factor: 6.961

7.  Pain sensitivity and opioid activity in genetically and experimentally hypertensive rats.

Authors:  N Zamir; R Simantov; M Segal
Journal:  Brain Res       Date:  1980-02-24       Impact factor: 3.252

8.  Evidence for two distinct perceptual alterations in irritable bowel syndrome.

Authors:  B D Naliboff; J Munakata; S Fullerton; R H Gracely; A Kodner; F Harraf; E A Mayer
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

Review 9.  The fibromyalgia syndrome: musculoskeletal pathophysiology.

Authors:  S E Geel
Journal:  Semin Arthritis Rheum       Date:  1994-04       Impact factor: 5.532

10.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

View more
  20 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

2.  Gut pain & visceral hypersensitivity.

Authors:  Adam D Farmer; Qasim Aziz
Journal:  Br J Pain       Date:  2013-02

3.  Increased beta-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome.

Authors:  Jung Ho Park; Poong-Lyul Rhee; Hyun Seo Kim; Jun Haeng Lee; Young-Ho Kim; Jae Jun Kim; Jong Chul Rhee; Eun Ho Kang; Bum-Hee Yu
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 4.  Pharmacogenetics and the treatment of functional gastrointestinal disorders.

Authors:  Houssam Halawi; Michael Camilleri
Journal:  Pharmacogenomics       Date:  2017-07-07       Impact factor: 2.533

Review 5.  New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments.

Authors:  Michael D Crowell; Lucinda Harris; Michael P Jones; Lin Chang
Journal:  Curr Gastroenterol Rep       Date:  2005-08

6.  Electroacupuncture reduces rectal distension-induced blood pressure changes in conscious dogs.

Authors:  Masahiro Iwa; Carmen Strickland; Yukiomi Nakade; Theodore N Pappas; Toku Takahashi
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

7.  Sex specific alterations in autonomic function among patients with irritable bowel syndrome.

Authors:  K Tillisch; E A Mayer; J S Labus; J Stains; L Chang; B D Naliboff
Journal:  Gut       Date:  2005-05-28       Impact factor: 23.059

8.  Autonomic function at rest and in response to emotional and rectal stimuli in women with irritable bowel syndrome.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 9.  Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors.

Authors:  Cornelia Kiank; Yvette Taché; Muriel Larauche
Journal:  Brain Behav Immun       Date:  2009-08-19       Impact factor: 7.217

Review 10.  Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging.

Authors:  Donald D Price; Jason G Craggs; QiQi Zhou; G Nicholas Verne; William M Perlstein; Michael E Robinson
Journal:  Neuroimage       Date:  2009-04-16       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.